| Literature DB >> 33138815 |
Adam Cole1, Jaya Telang2, Tae-Kyung Kim2, Kavya Swarna2, Ji Qi2, Casey Dauw2, Brian Seifman3, Mazen Abdelhady4, William Roberts2, John Hollingsworth2, Khurshid R Ghani2.
Abstract
BACKGROUND: Unplanned hospitalization following ureteroscopy (URS) for urinary stone disease is associated with patient morbidity and increased healthcare costs. To this effect, AUA guidelines recommend at least a urinalysis in patients prior to URS. We examined risk factors for infection-related hospitalization following URS for urinary stones in a surgical collaborative.Entities:
Keywords: Infection; Outcomes; Quality improvement; Ureteroscopy; Urolithiasis
Mesh:
Year: 2020 PMID: 33138815 PMCID: PMC7607640 DOI: 10.1186/s12894-020-00720-4
Source DB: PubMed Journal: BMC Urol ISSN: 1471-2490 Impact factor: 2.264
Fig. 1Post-operative hospitalization events following ureteroscopy for urinary stones in 1817 patients in a statewide surgical collaborative (MUSIC)
Patient characteristics for patients undergoing ureteroscopy for urinary stones in MUSIC ROCKS stratified by post-operative course
| Risk factor | Infection-related hospitalization (n = 43) | Non-hospitalized (n = 1737) | |
|---|---|---|---|
| Public insurance | 25 (58.1%) | 669 (39.7%) | 0.01 |
| Mean age (SD) | 60.1 (15.8) | 54.4 (15.5) | 0.02 |
| Male gender | 19 (44.2%) | 867 (50.1%) | 0.44 |
| BMI > 30 | 24 (58.5%) | 788 (46.8%) | 0.13 |
| CCI ≥ 1 | 26 (60.5%) | 495 (28.5%) | < 0.01 |
| CCI ≥ 2 | 14 (32.6%) | 241 (13.9%) | < 0.01 |
| Presence of hydronephrosis on pre-operative imaging | 27 (67.5%) | 1048 (66.7%) | 0.92 |
| Largest stone size (mm), mean (SD) | 10.1 (6.5) | 7.8 (5.4) | < 0.01 |
| Solitary kidney | 2 (4.7%) | 25 (1.5%) | 0.13 |
| Horseshoe kidney | 1 (2.3%) | 6 (0.4%) | 0.16 |
| History of recurrent UTI | 9 (20.9%) | 88 (5.1%) | < 0.01 |
| Urinary diversion | 2 (4.7%) | 7 (0.4%) | 0.02 |
| Spinal cord injury | 2 (4.7%) | 3 (0.2%) | < 0.01 |
| Anti-platelet therapy | 13 (30.2%) | 345 (20.4%) | 0.12 |
| Pre-operative urinalysis/urine culture not performed | 9 (20.9%) | 355 (20.5%) | 0.95 |
| Positive pre-operative urinalysis/urine culture | 12 (27.9%) | 266 (15.4%) | 0.08 |
| Positive pre-operative urinalysis/urine culture treated | 0 (0%) | 59 (22.2%) | 0.07 |
| Urgent/emergent surgery | 1 (2.3%) | 146 (8.4%) | 0.15 |
| Peri-operative antibiotic use | 38 (95%) | 1513 (96.9%) | 0.49 |
| Alpha-blocker therapy prior to URS | 11 (26.2%) | 755 (45.1%) | 0.01 |
| Pre-stenting (ureteral stent in place) | 20 (46.5%) | 649 (37.5%) | 0.23 |
| Renal | 17 (45.9%) | 502 (31.0%) | 0.07 |
| Ureter | 14 (37.8%) | 906 (56.0%) | |
| Both | 6 (16.2%) | 211 (13.0%) | |
| Intra-operative complication | 3 (7.0%) | 33 (1.9%) | < 0.01 |
| Complication: bleeding | 2 (4.7%) | 14 (0.8) | |
| Complication: perforation | 0 (0.0%) | 4 (0.2%) | |
| Complication: other | 1 (2.3%) | 15 (0.9%) | |
| Ureteral dilation | 6 (13.9%) | 340 (19.7%) | 0.44 |
| Ureteral access sheath use | 18 (41.9%) | 626 (36.6%) | 0.49 |
| Lithotripsy with fragments left in-situ | 30 (69.8%) | 716 (42.3%) | < 0.01 |
| Stenting during URS | 31 (72.1%) | 1248 (72.1%) | 0.99 |
| Discharged with antibiotics | 15 (36.6%) | 638 (39.2%) | 0.74 |
| Discharged with antibiotics and stent placed | 9 (20.9%) | 509 (29.3%) | 0.23 |
| Discharged with alpha-blocker | 27 (65.8%) | 911 (55.9%) | 0.21 |
| Stone free rate | 19 (57.6%) | 579 (77.5%) | < 0.01 |
Multi-variable logistic regression demonstrating association between patient characteristics and risk of infection-related hospitalization
| Risk factor | OR | CI | |
|---|---|---|---|
| Age | 1.01 | 0.98–1.03 | 0.95 |
| Comorbidity (CCI 0 vs. 1) | 3.12 | 1.37–7.14 | < 0.01 |
| Comorbidity (CCI 0 vs. 2) | 2.72 | 1.16–6.37 | 0.02 |
| Stone size | 1.04 | 1.01–1.07 | 0.02 |
| History of recurrent UTI | 3.74 | 1.55–9.00 | < 0.01 |
| Insurance (public vs. private) | 1.57 | 0.75–3.25 | 0.23 |
| Alpha-blocker prior to URS | 0.51 | 0.24–1.06 | 0.07 |
| Complete fragment removal | 0.32 | 0.16–0.65 | < 0.01 |
| Intra-operative complication | 3.70 | 1.22–11.25 | 0.02 |